
Sign up to save your podcasts
Or


On today’s podcast, Jean-Philip Piquemal, the chief scientific officer and co-founder of Qubit Pharmaceuticals, explains how the company’s Atlas platform is leading the way to more effective and safer drugs.
00:54-01:52: The history of Qubit Pharmaceuticals
01:52-04:04: What is the Atlas software?
04:04-05:18: Failing quickly is the key
05:19-06:53: What are digital twins?
06:54-09:00: Improving safety, reducing costs, and boosting drug discovery
09:00-10:44: Areas of interest
10:44-13:21: Recent successes
13:23-14:57: Preparing for future pandemics
14:58-17:03: Staying ahead of other companies
17:04-18:29: Enough diseases to go around
18:30-20:11: Upgrading Atlas software
20:13-21:59: How Qubit works with pharma companies
21:59-24:41: The Quantum for Bio program
24:42-27:58: Looking to the future, and helping patients
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
By Labiotech3.3
33 ratings
On today’s podcast, Jean-Philip Piquemal, the chief scientific officer and co-founder of Qubit Pharmaceuticals, explains how the company’s Atlas platform is leading the way to more effective and safer drugs.
00:54-01:52: The history of Qubit Pharmaceuticals
01:52-04:04: What is the Atlas software?
04:04-05:18: Failing quickly is the key
05:19-06:53: What are digital twins?
06:54-09:00: Improving safety, reducing costs, and boosting drug discovery
09:00-10:44: Areas of interest
10:44-13:21: Recent successes
13:23-14:57: Preparing for future pandemics
14:58-17:03: Staying ahead of other companies
17:04-18:29: Enough diseases to go around
18:30-20:11: Upgrading Atlas software
20:13-21:59: How Qubit works with pharma companies
21:59-24:41: The Quantum for Bio program
24:42-27:58: Looking to the future, and helping patients
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter

43,592 Listeners

537 Listeners

2,686 Listeners

2,451 Listeners

125 Listeners

320 Listeners

62 Listeners

5,552 Listeners

86 Listeners

34 Listeners

503 Listeners

148 Listeners

15,955 Listeners

18 Listeners

96 Listeners